Market Overview
The Mexico Growth Hormone Deficiency Clinical Trials Market was valued at USD 98 million in 2023 and is projected to grow at a CAGR of 4.9% from 2024 to 2030, reaching nearly USD 136.98 million by 2030. The market is benefiting from increasing clinical research activities, growing awareness of growth hormone deficiency (GHD), improvements in...
English
Arabic
French
Spanish
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek